Dbv Technologies DBV.PA · EUR

Its shares trade on Euronext Paris under the ticker DBV.PA. It has been listed since 29 March 2012. In the fiscal year to 31 December 2024, it reported revenue of $4.2m and a net loss of $114.1m. At that date it held total assets of $65.5m and shareholders' equity of $27.4m.

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, Ile-De-France. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Michel de RosenNon-Executive Independent Chairman of the Board$167,968
• Mr. Daniel TasseChief Executive Officer, Director, since 2018$1.5m
• Ms. Virginie BoucinhaChief Financial Officer$458,450
• Mr. James BriggsChief Human Resources Officer
• Dr. Pharis MohideenChief Medical Officer$820,762
• Ms. Mailys FerrereNon-Executive Independent Director
• Mr. Michael GollerNon-Executive Independent Director$115,478
• Ms. Daniele Guyot-CaparrosNon-Executive Independent Director$115,478
• Mr. Timothy MorrisNon-Executive Independent Director$125,976
• Dr. Adora NduNon-Executive Independent Director$110,229
• Ms. Julie O'NeillNon-Executive Independent Director$115,478
• Dr. Ravi RaoNon-Executive Independent Director$110,229

Overall

52

Environment

59

Social

32

Governance

67

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.